Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
ERIS Lifesciences LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:540596NSE Symbol: ERISP/E(TTM):300.41
ISIN Demat:INE406M01024Div & Yield %:0.43EPS(TTM):5.68
Book Value(Rs):184.651184Market Cap ( Cr.):23240.03Face Value(Rs):1
    Change Company 
(Rs In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
SOURCES OF FUNDS :      
Share Capital 13.6213.6013.6013.5913.5813.58
Reserves Total 2501.282510.422208.291904.511561.891286.12
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.450.000.00
Total Shareholders Funds2514.902524.022221.891918.551575.471299.70
Secured Loans 820.452432.84316.870.000.000.00
Unsecured Loans 1424.42139.140.000.000.000.00
Total Debt2244.872571.98316.870.000.000.00
Other Liabilities58.9442.8068.5365.6234.8833.99
Total Liabilities4818.715138.802607.291984.171610.351333.69
APPLICATION OF FUNDS :      
Gross Block 2875.211811.211094.83778.40716.88695.65
Less : Accumulated Depreciation 463.03295.65197.02136.40132.5595.01
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 2412.181515.56897.81642.00584.33600.64
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress0.270.610.342.981.564.37
Producing Properties0.000.000.000.000.000.00
Investments 991.271618.95996.52777.72531.37320.30
Current Assets, Loans & Advances      
Inventories 191.2591.6363.7084.7964.8565.46
Sundry Debtors 236.19239.97229.22137.56113.76140.82
Cash and Bank92.461296.7347.6546.1132.6664.95
Loans and Advances 107.64248.21181.50212.02161.98104.09
Total Current Assets627.541876.54522.07480.47373.24375.32
Less : Current Liabilities and Provisions      
Current Liabilities 358.80168.08114.10123.38110.08114.34
Provisions 44.9242.6962.2742.8634.3835.10
Total Current Liabilities403.72210.77176.37166.24144.46149.44
Net Current Assets223.821665.77345.70314.23228.78225.89
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets576.71485.09399.14350.70297.27240.62
Deferred Tax Liability293.35181.30125.36114.59100.5276.46
Net Deferred Tax283.36303.79273.78236.11196.75164.16
Other Assets907.8134.1293.1311.1467.5818.33
Total Assets4818.715138.802607.291984.191610.361333.69
Contingent Liabilities584.54332.46630.3924.3418.3215.81